Workup of Parkinson's Disease, Parkinson Plus, Lewy Body, and Alzheimer's Dementia Should Include SPECT, PET and Genetics

Workup of Parkinson's Disease, Parkinson Plus, Lewy Body, and Alzheimer's Dementia Should Include SPECT, PET and Genetics

Saved in:

Bibliographic Details
Main Author:	Josef Finsterer
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Health Science Reports
Online Access:	https://doi.org/10.1002/hsr2.70197
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SPECT Findings in Alzheimer’s Disease and Parkinson’s Disease with Dementia
by: S. E. Starkstein, et al.
Published: (1997-01-01)

Cortical Lewy Body Dementia
by: W. R. G. Gibb
Published: (1990-01-01)

Spatial Perseveration in Dementia with Lewy Bodies
by: Frédéric Assal, et al.
Published: (2007-01-01)

Age-dependent alpha-synuclein aggregation and Lewy body formation in Parkinson’s disease
by: Chun Chau Sung, et al.
Published: (2025-12-01)

Coffee and tea are unlikely to be risk factors or preventers of Alzheimer's disease or vascular dementia
by: Josef Finsterer
Published: (2025-02-01)

Behavioural and Cognitive Changes in Lewy Body Dementias
by: Woon-Man Kung, et al.
Published: (2018-01-01)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
by: Hossein Moein Taghavi, et al.
Published: (2024-10-01)

Metabolic Risk Factors of Alzheimer’s Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study
by: Chih-Kuang Cheng, et al.
Published: (2018-01-01)

SPECT and PET Imaging of Meningiomas
by: Varvara Valotassiou, et al.
Published: (2012-01-01)

REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
by: Po-Chi Chan, et al.
Published: (2018-01-01)

Preclinical Polymodal Hallucinations for 13 Years before Dementia with Lewy Bodies
by: Carlo Abbate, et al.
Published: (2014-01-01)

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
by: Fernando L. Pagan, et al.
Published: (2022-01-01)

Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism
by: Giorgio Fabiani, et al.
Published: (2022-01-01)

Effectiveness of Contrast Agents and Molecular Indicators in Alzheimer's Diagnosis Through PET and SPECT Imaging on Animal Models
by: Yasaman Abaszadeh, et al.
Published: (2025-01-01)

NOX2 in Alzheimer's and Parkinson's disease
by: Christopher M. Dustin, et al.
Published: (2024-12-01)

Alzheimer's and Parkinson's disease therapies in the clinic
by: Puja Chopade, et al.
Published: (2023-01-01)

Patients with dementia with Lewy bodies display a signature alteration of their cognitive connectome
by: Roraima Yanez-Perez, et al.
Published: (2025-01-01)

Incidence and Comorbidity of Dementia with Lewy Bodies: A Population-Based Cohort Study
by: Sheng-Kung Yang, et al.
Published: (2018-01-01)

An overview of methods for the treatment and diagnosis of dementia with Lewy bodies. Clinical case analysis
by: M. Š. Markevičiūtė, et al.
Published: (2020-12-01)

PET and SPECT Imaging of ALS: An Educational Review
by: Ayaan M. Jamali, et al.
Published: (2023-01-01)

Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
by: Emma D. Frost, et al.
Published: (2024-11-01)

Dementia with lewy bodies patients with high tau levels display unique proteome profiles
by: Sinead Greally, et al.
Published: (2024-12-01)

Bálint syndrome in dementia with Lewy bodies: A new phenotypic variant with progression implications?
by: R. Ghosh, et al.
Published: (2024-10-01)

Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT
by: Brian P. Rempel BSc, PhD, et al.
Published: (2017-09-01)

Is transcranial direct current stimulation really beneficial for frontotemporal dementia?
by: Josef Finsterer
Published: (2024-12-01)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
by: Iracema Leroi, et al.
Published: (2012-01-01)

The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies
by: Kathryn A. Wyman‐Chick, et al.
Published: (2024-10-01)

Impact of Lewy bodies disease on visual skills and memory abilities: from prodromal stages to dementia
by: Cinzia Bussè, et al.
Published: (2024-12-01)

Elevated plasma total homocysteine levels are associated with behavioral and psychological symptoms in dementia with Lewy bodies
by: Guili Zhang, et al.
Published: (2024-11-01)

The value of 18F⁃FDG PET in the diagnosis and differential diagnosis of Parkinson's disease and multiple system atrophy with parkinsonism⁃predominant
by: DU Xiao‐xiao, et al.
Published: (2024-12-01)

Association of Alzheimer’s and Lewy body disease pathology with basal forebrain volume and cognitive impairment
by: Julia Schumacher, et al.
Published: (2025-01-01)

Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control
by: Danyan Chen, et al.
Published: (2018-01-01)

Prosthetic Valve Candida Endocarditis: A Case Report with 18F-FDG-PET/CT as Part of the Diagnostic Workup
by: Soile Pauliina Salomäki, et al.
Published: (2020-01-01)

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam
by: Velmarini Vasquez, et al.
Published: (2024-12-01)

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
by: Simone A. van den Berge, et al.
Published: (2012-01-01)

Association analyses of nutritional markers with Parkinson’s disease and Alzheimer’s disease
by: Dong-Juan Xu, et al.
Published: (2024-11-01)

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
by: Jeffrey Fessel
Published: (2022-01-01)

Lewy body diseases and the gut
by: Timothy R. Sampson, et al.
Published: (2025-01-01)

Risk of Dementia in Patients with Depression or Parkinson’s Disease: A Retrospective Cohort Study
by: Ting-Chun Fang, et al.
Published: (2020-01-01)

Piece of Mind: knowledge translation performances for public engagement on Parkinson’s disease and dementia
by: Naila Kuhlmann, et al.
Published: (2024-11-01)